Reproductive Health News

Establishing and running a successful fertility preservation program for cancer survivors requires a multidisciplinary team effort, according to a presenter at the Cancer Center Survivorship Research Forum.

After the Dobbs decision in June 2022, the number of women traveling to Massachusetts for abortion care increased even though neighboring states did not have abortion restrictions, researchers reported in JAMA Network Open.

In July, the FDA approved norgestrel as the first nonprescription, over-the-counter daily oral contraceptive to prevent pregnancy.

Providing iron supplements during prenatal visits improved hematocrit levels and anemia rates and reduced transfusions for acute blood loss anemia among women with Medicaid insurance, researchers reported.

Telehealth medication abortion services help make abortion care access more convenient and accessible for underserved communities in the U.S., according to a cross-sectional study published in JAMA Network Open.

Analysis of the online conversation among health care professionals on social media in July revealed significant online discussion and support for the first-ever nonprescription daily oral contraceptive, norgestrel 0.075 mg.

Within 12 months after childbirth, women who underwent infertility treatment had an increased risk for stroke-related hospitalization, according to a large population-based, retrospective cohort study published in JAMA Network Open.

SAN DIEGO — Adherence to a low-carbohydrate diet during pregnancy may have some benefits in gestational diabetes, but overall, low-carbohydrate diets are not associated with any significant differences in outcomes, according to two experts.

Biomarker panels specific to different ethnicities may allow health care providers to better assess individuals women’s personal reproductive potential, according to a systematic review published in Reproductive Sciences.

Black and Hispanic premenopausal women are more likely to experience severe bleeding and other symptoms related to noncancerous gynecologic conditions before undergoing hysterectomy compared with white women.